{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T19:55:54Z","timestamp":1794081354943,"version":"4.8.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T00:00:00Z","timestamp":1556582400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T00:00:00Z","timestamp":1556582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12879-019-3965-8","type":"journal-article","created":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T12:04:24Z","timestamp":1556625864000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Clostridium difficile isolated from faecal samples in patients with ulcerative colitis"],"prefix":"10.1186","volume":"19","author":[{"given":"Parisa","family":"Shoaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Shojaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Jalali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzin","family":"Khorvash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayed Mohsen","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behrooz","family":"Ataei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahareh","family":"Vakili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Ebrahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Tavakoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Esfandiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Scott","family":"Weese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,30]]},"reference":[{"issue":"9","key":"3965_CR1","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1007\/s10620-014-3169-4","volume":"59","author":"SK Hourigan","year":"2014","unstructured":"Hourigan SK, Oliva-Hemker M, Hutfless S. The prevalence of Clostridium difficile infection in pediatric and adult patients with inflammatory bowel disease. Dig Dis Sci. 2014;59(9):2222\u20137. \n                    https:\/\/doi.org\/10.1007\/s10620-014-3169-4\n                    \n                  .","journal-title":"Dig Dis Sci"},{"issue":"9","key":"3965_CR2","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1128\/JCM.02437-07","volume":"46","author":"H Martin","year":"2008","unstructured":"Martin H, Willey B, Low DE, Staempfli HR, McGeer A, Boerlin P, Mulvey M, Weese JS. Characterization of Clostridium difficile strains isolated from patients in Ontario, Canada, from 2004 to 2006. J Clin Microbiol. 2008;46(9):2999\u20133004. \n                    https:\/\/doi.org\/10.1128\/JCM.02437-07\n                    \n                  .","journal-title":"J Clin Microbiol"},{"issue":"2","key":"3965_CR3","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/j.1574-6968.1999.tb13629.x","volume":"175","author":"P Bidet","year":"1999","unstructured":"Bidet P, Barbut F, Lalande V, Burghoffer B, Petit JC. Development of a new PCR-ribotyping method for Clostridium difficile based on ribosomal RNA gene sequencing. FEMS Microbiol Lett. 1999;175(2):261\u20136.","journal-title":"FEMS Microbiol Lett"},{"issue":"1","key":"3965_CR4","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/1756-0500-5-159","volume":"5","author":"M Jalali","year":"2012","unstructured":"Jalali M, Khorvash F, Warriner K, Weese JS. Clostridium difficile infection in an Iranian hospital. BMC Res Notes. 2012;5(1):159. \n                    https:\/\/doi.org\/10.1186\/1756-0500-5-159\n                    \n                  .","journal-title":"BMC Res Notes"},{"issue":"3","key":"3965_CR5","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1128\/JCM.01796-09","volume":"48","author":"D Griffiths","year":"2010","unstructured":"Griffiths D, Fawley W, Kachrimanidou M, Bowden R, Crook DW, Fung R, Golubchik T, Harding RM, Jeffery KJ, Jolley KA, Kirton R, Peto TE, Rees G, Stoesser N, Vaughan A, Walker AS, Young BC, Wilcox M, Dingle KE. Multilocus sequence typing of Clostridium difficile. J Clin Microbiol. 2010;48(3):770\u20138. \n                    https:\/\/doi.org\/10.1128\/JCM.01796-09\n                    \n                  .","journal-title":"J Clin Microbiol"},{"issue":"6","key":"3965_CR6","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1128\/JCM.42.6.2609-2617.2004","volume":"42","author":"L Lemee","year":"2004","unstructured":"Lemee L, Dhalluin A, Pestel-Caron M, Lemeland J-F, Pons J-L. Multilocus sequence typing analysis of human and animal Clostridium difficile isolates of various toxigenic types. J Clin Microbiol. 2004;42(6):2609\u201317.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"3965_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0031559","volume":"7","author":"RA Stabler","year":"2012","unstructured":"Stabler RA, Dawson LF, Valiente E, Cairns MD, Martin MJ, Donahue EH, Riley TV, Songer JG, Kuijper EJ, Dingle KE, Wren BW. Macro and microdiversity of Clostridium difficile isolates from diverse sources and geographical locations. PLoS One. 2012;7(3):e31559. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0031559\n                    \n                  .","journal-title":"PLoS One"},{"issue":"5","key":"3965_CR8","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/ajg.2016.106","volume":"111","author":"ME Negr\u00f3n","year":"2016","unstructured":"Negr\u00f3n ME, Rezaie A, Barkema HW, Rioux K, De Buck J, Checkley S, Beck PL, Carroll M, Fedorak RN, Dieleman L. Ulcerative colitis patients with Clostridium difficile are at increased risk of death, colectomy, and postoperative complications: a population-based inception cohort study. Am J Gastroenterol. 2016;111(5):691.","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"3965_CR9","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1111\/j.1572-0241.2007.01780.x","volume":"103","author":"GC Nguyen","year":"2008","unstructured":"Nguyen GC, Kaplan GG, Harris ML, Brant SR. A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients. Am J Gastroenterol. 2008;103(6):1443.","journal-title":"Am J Gastroenterol"},{"key":"3965_CR10","doi-asserted-by":"crossref","unstructured":"Berg AM, Kelly CP, Farraye FA (2012) Clostridium difficile infection in the inflammatory bowel disease patient. Inflammatory bowel diseases.","DOI":"10.14309\/00000434-201210001-01534"},{"issue":"7","key":"3965_CR11","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/cix1085","volume":"66","author":"L Clifford McDonald","year":"2018","unstructured":"McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, Dubberke ER, Garey KW, Gould CV, Kelly C. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018;66(7):e1\u201348.","journal-title":"Clinical Infectious Diseases"},{"key":"3965_CR12","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/136064","volume":"2011","author":"P Sinh","year":"2011","unstructured":"Sinh P, Barrett TA, Yun L. Clostridium difficile infection and inflammatory bowel disease: a review. Gastroenterol Res Pract. 2011;2011:136064. \n                    https:\/\/doi.org\/10.1155\/2011\/136064\n                    \n                  .","journal-title":"Gastroenterol Res Pract"},{"issue":"1","key":"3965_CR13","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1093\/ecco-jcc\/jjw117","volume":"11","author":"NM Joshi","year":"2017","unstructured":"Joshi NM, Marks IH, Crowson R, Ball D, Rampton DS. Incidence and outcome of Clostridium difficile infection in hospitalized patients with inflammatory bowel disease in the UK. J Crohns Colitis. 2017;11(1):70\u20136. \n                    https:\/\/doi.org\/10.1093\/ecco-jcc\/jjw117\n                    \n                  .","journal-title":"J Crohns Colitis"},{"issue":"5","key":"3965_CR14","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1002\/ibd.21837","volume":"18","author":"A Banaszkiewicz","year":"2012","unstructured":"Banaszkiewicz A, Kowalska-Duplaga K, Pytrus T, Pituch H, Radzikowski A. Clostridium difficile infection in newly diagnosed pediatric patients with inflammatory bowel disease: prevalence and risk factors. Inflamm Bowel Dis. 2012;18(5):844\u20138. \n                    https:\/\/doi.org\/10.1002\/ibd.21837\n                    \n                  .","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"3965_CR15","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/DCR.0b013e31819733fd","volume":"52","author":"R Ricciardi","year":"2009","unstructured":"Ricciardi R, Ogilvie JW Jr, Roberts PL, Marcello PW, Concannon TW, Baxter NN. Epidemiology of Clostridium difficile colitis in hospitalized patients with inflammatory bowel diseases. Dis Colon rectum. 2009;52(1):40\u20135. \n                    https:\/\/doi.org\/10.1007\/DCR.0b013e31819733fd\n                    \n                  .","journal-title":"Dis Colon rectum"},{"issue":"7","key":"3965_CR16","doi-asserted-by":"publisher","first-page":"e99","DOI":"10.1038\/ctg.2015.24","volume":"6","author":"SM Vindigni","year":"2015","unstructured":"Vindigni SM, Surawicz CM. C. difficile infection: changing epidemiology and management paradigms. Clin Transl Gastroenterol. 2015;6(7):e99. \n                    https:\/\/doi.org\/10.1038\/ctg.2015.24\n                    \n                  .","journal-title":"Clin Transl Gastroenterol"},{"key":"3965_CR17","doi-asserted-by":"crossref","unstructured":"D\u2019Aoust J, Battat R, T B. Management of inflammatory bowel disease with Clostridium difficile infection. 2017;23(27):4986.","DOI":"10.3748\/wjg.v23.i27.4986"},{"key":"3965_CR18","doi-asserted-by":"crossref","unstructured":"Surawicz CM, Brandt LJ, Binion DG, Ananthakrishnan AN, Curry SR, Gilligan PH, McFarland LV, Mellow M, BS Z. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. 2013;108(4):478.","DOI":"10.1038\/ajg.2013.4"},{"issue":"1","key":"3965_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/01.MPG.0000163736.30261.82","volume":"41","author":"J Escher","year":"2005","unstructured":"Escher J. Inflammatory bowel disease in children and adolescents: recommendations for diagnosis-the Porto criteria. J Pediatr Gastroenterol Nutr. 2005;41(1):1\u20137.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"11","key":"3965_CR20","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.3201\/eid1211.051581","volume":"12","author":"A Rodriguez-Palacios","year":"2006","unstructured":"Rodriguez-Palacios A, Stampfli HR, Duffield T, Peregrine AS, Trotz-Williams LA, Arroyo LG, Brazier JS, Weese JS. Clostridium difficile PCR ribotypes in calves, Canada. Emerg Infect Dis. 2006;12(11):1730\u20136. \n                    https:\/\/doi.org\/10.3201\/eid1211.051581\n                    \n                  .","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"3965_CR21","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s10620-009-0749-9","volume":"55","author":"D Jodorkovsky","year":"2010","unstructured":"Jodorkovsky D, Young Y, Abreu MT. Clinical outcomes of patients with ulcerative colitis and co-existing Clostridium difficile infection. Dig Dis Sci. 2010;55(2):415\u201320. \n                    https:\/\/doi.org\/10.1007\/s10620-009-0749-9\n                    \n                  .","journal-title":"Dig Dis Sci"},{"issue":"1","key":"3965_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1745-6215-8-17","volume":"8","author":"RM Cooney","year":"2007","unstructured":"Cooney RM, Warren BF, Altman DG, Abreu MT, Travis SP. Outcome measurement in clinical trials for ulcerative Colitis: towards standardization. Trials. 2007;8(1):17. \n                    https:\/\/doi.org\/10.1186\/1745-6215-8-17\n                    \n                  .","journal-title":"Trials"},{"key":"3965_CR23","doi-asserted-by":"crossref","unstructured":"Garcia PG, Chebli LA, da Rocha Ribeiro TC, Gaburri PD, de Lima Pace FH, Barbosa KVBD, Costa LA, de Almeida Cruz W, de Assis IC, Moraes BRMJIjocd (2018) Impact of superimposed Clostridium difficile infection in Crohn\u2019s or ulcerative colitis flares in the outpatient setting.1\u201310.","DOI":"10.1007\/s00384-018-3105-8"},{"issue":"12","key":"3965_CR24","doi-asserted-by":"publisher","first-page":"5710","DOI":"10.1128\/JCM.42.12.5710-5714.2004","volume":"42","author":"L Lemee","year":"2004","unstructured":"Lemee L, Dhalluin A, Testelin S, Mattrat MA, Maillard K, Lemeland JF, Pons JL. Multiplex PCR targeting tpi (triose phosphate isomerase), tcdA (toxin a), and tcdB (toxin B) genes for toxigenic culture of clostridium difficile. J Clin Microbiol. 2004;42(12):5710\u20134. \n                    https:\/\/doi.org\/10.1128\/JCM.42.12.5710-5714.2004\n                    \n                  .","journal-title":"J Clin Microbiol"},{"key":"3965_CR25","unstructured":"Bouillaut L, McBride SM, Sorg JA (2011) Genetic manipulation of Clostridium difficile. 20 (1):9A. 2.1-9A. 2.17."},{"issue":"4","key":"3965_CR26","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/j.1472-765X.1989.tb00262.x","volume":"8","author":"D Pitcher","year":"1989","unstructured":"Pitcher D, Saunders N, Owen R. Rapid extraction of bacterial genomic DNA with guanidium thiocyanate. Lett Appl Microbiol. 1989;8(4):151\u20136.","journal-title":"Lett Appl Microbiol"},{"issue":"2","key":"3965_CR27","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j.1574-6968.2000.tb09122.x","volume":"186","author":"S Stubbs","year":"2000","unstructured":"Stubbs S, Rupnik M, Gibert M, Brazier J, Duerden B, Popoff M. Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile. FEMS Microbiol Lett. 2000;186(2):307\u201312. \n                    https:\/\/doi.org\/10.1111\/j.1574-6968.2000.tb09122.x\n                    \n                  .","journal-title":"FEMS Microbiol Lett"},{"issue":"3","key":"3965_CR28","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.cgh.2006.12.027","volume":"5","author":"JF Rodemann","year":"2007","unstructured":"Rodemann JF, Dubberke ER, Reske KA, Seo DH, Stone CD. Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007;5(3):339\u201344. \n                    https:\/\/doi.org\/10.1016\/j.cgh.2006.12.027\n                    \n                  .","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3965_CR29","doi-asserted-by":"crossref","unstructured":"Fraga EG, Nicodemo AC, Sampaio JL (2016) Antimicrobial susceptibility of Brazilian Clostridium difficile strains determined by agar dilution and disk diffusion. 20 (5):476\u2013481.","DOI":"10.1016\/j.bjid.2016.07.004"},{"issue":"8","key":"3965_CR30","doi-asserted-by":"publisher","first-page":"E266","DOI":"10.1111\/j.1469-0691.2012.03907.x","volume":"18","author":"L.T. Erikstrup","year":"2012","unstructured":"Erikstrup LT, Danielsen T, Hall V, Olsen K, Kristensen B, Kahlmeter G, Fuursted K, Justesen US. Antimicrobial susceptibility testing of Clostridium difficile using EUCAST epidemiological cut-off values and disk diffusion correlates. Clin Microbiol Infect. 2012;18(8):E266-72.","journal-title":"Clinical Microbiology and Infection"},{"issue":"39","key":"3965_CR31","doi-asserted-by":"publisher","first-page":"4892","DOI":"10.3748\/wjg.v16.i39.4892","volume":"16","author":"U Navaneethan","year":"2010","unstructured":"Navaneethan U, Venkatesh PG, Shen B. Clostridium difficile infection and inflammatory bowel disease: understanding the evolving relationship. World J Gastroenterol. 2010;16(39):4892\u2013904.","journal-title":"World J Gastroenterol"},{"key":"3965_CR32","unstructured":"Kim DB, Lee K-M, Park SH, Kim YS, Kim ES, Lee J, Jung S, Seo GS, JMJIr L. Is Clostridium difficile infection a real threat in patients with ulcerative colitis? A prospective, multicenter study in Korea. 2018;16(2):267\u201372."},{"key":"3965_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/4803262","volume":"2017","author":"William Gillespie","year":"2017","unstructured":"Gillespie W, Marya N, Fahed J, Leslie G, Patel K, Cave DR, Practice (2017) Clostridium difficile in inflammatory bowel disease: a retrospective study. 2017.","journal-title":"Gastroenterology Research and Practice"},{"issue":"1","key":"3965_CR34","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.crohns.2010.09.007","volume":"5","author":"R Kariv","year":"2011","unstructured":"Kariv R, Navaneethan U, Venkatesh PG, Lopez R, Shen B. Impact of Clostridium difficile infection in patients with ulcerative colitis. J Crohns Colitis. 2011;5(1):34\u201340. \n                    https:\/\/doi.org\/10.1016\/j.crohns.2010.09.007\n                    \n                  .","journal-title":"J Crohns Colitis"},{"issue":"9","key":"3965_CR35","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.cgh.2009.05.031","volume":"7","author":"S Ben-Horin","year":"2009","unstructured":"Ben-Horin S, Margalit M, Bossuyt P, Maul J, Shapira Y, Bojic D, Chermesh I, Al-Rifai A, Schoepfer A, Bosani M, Allez M, Lakatos PL, Bossa F, Eser A, Stefanelli T, Carbonnel F, Katsanos K, Checchin D, Miera IS, Chowers Y, Moran GW, Cs E, Colitis O. Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and Clostridium difficile infection. Clin Gastroenterol Hepatol. 2009;7(9):981\u20137. \n                    https:\/\/doi.org\/10.1016\/j.cgh.2009.05.031\n                    \n                  .","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"3965_CR36","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1002\/ibd.20500","volume":"14","author":"M Issa","year":"2008","unstructured":"Issa M, Ananthakrishnan AN, Binion DG. Clostridium difficile and inflammatory bowel disease. Inflamm Bowel Dis. 2008;14(10):1432\u201342. \n                    https:\/\/doi.org\/10.1002\/ibd.20500\n                    \n                  .","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"3965_CR37","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1128\/JCM.38.6.2386-2388.2000","volume":"38","author":"F Barbut","year":"2000","unstructured":"Barbut F, Richard A, Hamadi K, Chomette V, Burghoffer B, Petit J-C. Epidemiology of recurrences or reinfections ofClostridium difficile-associated diarrhea. J Clin Microbiol. 2000;38(6):2386\u20138.","journal-title":"J Clin Microbiol"},{"issue":"8","key":"3965_CR38","doi-asserted-by":"publisher","first-page":"704","DOI":"10.5812\/ircmj.5189","volume":"15","author":"M Goudarzi","year":"2013","unstructured":"Goudarzi M, Goudarzi H, Alebouyeh M, Azimi Rad M, Shayegan Mehr FS, Zali MR, Aslani MM. Antimicrobial susceptibility of Clostridium difficile clinical isolates in Iran. Iran Red Crescent Med J. 2013;15(8):704\u201311. \n                    https:\/\/doi.org\/10.5812\/ircmj.5189\n                    \n                  .","journal-title":"Iran Red Crescent Med J"},{"key":"3965_CR39","doi-asserted-by":"crossref","unstructured":"Wang R, Suo L, Chen HX, Song LJ, Shen YY, Luo YP. Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolated from the Chinese People\u2019s Liberation Army General Hospital in China. 2018;67:86\u201391.","DOI":"10.1016\/j.ijid.2017.07.010"},{"issue":"1","key":"3965_CR40","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/1471-2458-14-119","volume":"14","author":"E Rahimi","year":"2014","unstructured":"Rahimi E, Jalali M, Weese JS. Prevalence of Clostridium difficile in raw beef, cow, sheep, goat, camel and buffalo meat in Iran. BMC Public Health. 2014;14(1):119. \n                    https:\/\/doi.org\/10.1186\/1471-2458-14-119\n                    \n                  .","journal-title":"BMC Public Health"},{"key":"3965_CR41","doi-asserted-by":"crossref","unstructured":"Chen Y-B, Gu S-L, Wei Z-Q, Shen P, Kong H-S, Yang Q, Li LJ. Molecular epidemiology of Clostridium difficile in a tertiary hospital of China. 2014;63(4):562\u20139.","DOI":"10.1099\/jmm.0.068668-0"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-3965-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-3965-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-3965-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T09:41:46Z","timestamp":1589881306000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-3965-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,30]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3965"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-3965-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,30]]},"assertion":[{"value":"3 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Ethics Committee on Clinical Investigation of the Isfahan University of Medical Sciences, Isfahan, Iran, approved this presented research. Written consent informed was obtained from all participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"361"}}